For the bottom price, I agree with @Titans19. RAC should be valued at a minimum as a salvage drug. That's the worst case scenario for us investors IMO. We know the drug works, it's just a matter of proving that fact.
IMO that should be the ground floor valuation for RAC, i.e multiples of where we are now.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.005(0.43%) |
Mkt cap ! $204.1M | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.18 | $1.17 | $1.918K | 1.635K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 8256 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 466 | 1 |
View Market Depth
| Last trade - 10.29am 14/07/2025 (20 minute delay) ? |
| RAC (ASX) Chart |